Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide decitabine to patients with Acute Myeloid Leukemia
(AML) or Myelodysplastic Syndrome (MDS) who have completed participation per protocol in the
DACO-018 study.